VALIDATION IMAGES
Lane 1: Jurkat; Lane 2: Hela; Lane 3: C2C12 lysate probed with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:300 in HeLa cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:300 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:300 in A549 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Mouse spleen tissue incubated with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human tonsil tissue incubated with Caspase-9 (2A7) Monoclonal Antibody (bsm-52314R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.